GE HealthCare has received the US Food and Drug Administration (FDA) 510(k) approval for its CARESCAPE Canvas patient monitoring platform for precise, flexible patient care.

CARESCAPE Canvas, together with CARESCAPE ONE, is part of an ecosystem that can easily scale up and scale down monitoring capabilities based on the acuity of each patient.

The medical technology company said that the monitoring platform is a FlexAcutity solution, equipped with smart parameter technology that can be used for patients at all levels of acuity.

CARESCAPE Canvas offers flexibility and standardisation by leveraging micromodules that connect with medical USB technology.

It enables effective care as per the patient care needs, through simple connection or disconnection of cables provided for different configurations.

Furthermore, the platform is equipped with advanced software and interchangeable frames, to enable the monitoring devices rapidly redeployed across the hospital enterprise.

GE HealthCare monitoring solutions general manager Neal Sandy said: “This new monitoring ecosystem has the potential for a hospital to have one single unified approach to patient monitoring that can be easily tailored for each patient.

“GE HealthCare is committed to offering flexible solutions that enable care teams to focus on the patient, not the technology.

“CARESCAPE Canvas’ innovative approach, where software and patient parameters can change in a very nimble manner, enables a standardised ecosystem that can adapt to changing healthcare needs.”

GE HealthCare manufactures its CARESCAPE Canvas monitors at its Helsinki site, using 100% renewable wind electricity.

It has developed and tested the new bedside monitoring device, not only with the current devices, but also with previous versions in the ecosystem.

The backward compatibility will enable the healthcare systems to upgrade to the newest patient monitoring capabilities at their pace, said the company.

In addition, the platform has been developed with 53% less packaging volume, 48% less packaging weight, and consumes 25% less energy than previous versions and models.

In June last year, GE HealthCare secured regulatory approval for use of CARESCAPE Canvas in the European Union (EU).